Complete Filing Data
Disc Medicine, Inc. reported Stockholders Equity of $739.83 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Disc Medicine, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$212.2M | -$109.4M | -$76.4M | -$46.8M | -$36.0M | -$40.8M |
| Operating Income Loss | -$236.0M | -$129.7M | -$91.1M | -$47.5M | -$30.9M | -$34.0M |
| Research And Development Expense | $170.6M | $96.7M | $69.3M | $33.4M | $25.2M | $28.2M |
| Operating Expenses | $236.0M | $129.7M | $91.1M | $47.5M | $30.9M | $34.0M |
| General And Administrative Expense | $21.9M | $14.0M | $5.8M | $5.9M | ||
| Other Nonoperating Income Expense | $45.0K | -$2.0K | -$2.0K | $0.00 | -$13.0K | |
| Nonoperating Income Expense | $24.2M | $20.7M | $14.8M | $648.0K | -$5.0M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$211.8M | -$109.0M | -$76.3M | -$46.8M | ||
| Income Tax Expense Benefit | $361.0K | $355.0K | $99.0K | $0.00 | ||
| Net Income Loss Available To Common Stockholders Basic | -$76.4M | -$46.8M | -$36.0M | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.0K | -$27.0K | $0.00 | |||
| Net Income Loss Available To Common Stockholders Diluted | -$76.4M | -$46.8M | -$36.0M | |||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $676.0K | $289.0K | $0.00 | |||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $677.0K | $316.0K | $0.00 | |||
| Comprehensive Income Net Of Tax | -$211.5M | -$109.1M | -$76.4M | |||
| Interest Expense | $2.2M | $6.8M | ||||
| Income Taxes Paid Net | $299.0K | $112.0K | $0.00 | $0.00 | ||
| Selling General And Administrative Expense | $65.4M | $33.0M | $21.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$62.3M | -$55.2M | -$34.1M | -$26.6M | -$26.4M | -$26.9M | -$14.1M | -$15.9M | -$22.8M | -$16.2M | -$9.6M | -$9.9M | -$18.6M | -$16.4M | -$19.0M | -$10.0M | -$6.8M | -$9.7M |
| Operating Income Loss | -$67.7M | -$61.4M | -$39.9M | -$32.9M | -$30.9M | -$31.5M | -$19.0M | -$17.3M | -$25.1M | -$10.5M | -$12.0M | -$10.0M | -$18.5M | -$16.3M | -$16.5M | -$7.9M | -$6.7M | -$9.6M |
| Research And Development Expense | $50.3M | $46.3M | $27.8M | $24.7M | $23.5M | $23.7M | $14.4M | $12.1M | $20.2M | $7.9M | $7.7M | $7.8M | $13.5M | $10.8M | $11.8M | $6.7M | $5.5M | $8.2M |
| Operating Expenses | $67.7M | $61.4M | $39.9M | $32.9M | $30.9M | $31.5M | $19.0M | $17.3M | $25.1M | $10.5M | $12.0M | $10.0M | $18.5M | $16.3M | $16.5M | $7.9M | $6.7M | $9.6M |
| General And Administrative Expense | $8.2M | $7.4M | $7.8M | $4.5M | $5.2M | $4.9M | $2.6M | $4.3M | $2.1M | $5.0M | $5.5M | $4.7M | $1.2M | $1.1M | $1.4M | |||
| Other Nonoperating Income Expense | -$18.0K | $68.0K | -$3.0K | $9.0K | -$13.0K | -$1.0K | $13.0K | -$5.0K | $0.00 | $0.00 | $0.00 | $3.0K | -$2.0K | -$11.0K | $0.00 | |||
| Nonoperating Income Expense | $5.5M | $6.2M | $6.0M | $6.4M | $4.6M | $4.5M | $4.9M | $1.4M | $2.4M | -$5.7M | $2.4M | $107.0K | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$62.2M | -$55.2M | -$34.0M | -$26.5M | -$26.3M | -$26.9M | -$14.1M | -$15.9M | -$22.8M | -$16.2M | -$9.6M | -$9.9M | ||||||
| Income Tax Expense Benefit | $102.0K | $52.0K | $119.0K | $114.0K | $60.0K | $5.0K | $20.0K | $24.0K | $23.0K | $0.00 | $0.00 | |||||||
| Net Income Loss Available To Common Stockholders Basic | -$26.6M | -$26.4M | -$26.9M | -$14.1M | -$15.9M | -$22.8M | -$16.2M | -$9.6M | -$9.9M | -$16.4M | -$19.0M | -$6.8M | -$9.7M | |||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $0.00 | -$15.0K | $14.0K | -$48.0K | $6.0K | $0.00 | $0.00 | $0.00 | ||||||||||
| Net Income Loss Available To Common Stockholders Diluted | -$26.6M | -$26.4M | -$26.9M | -$14.1M | -$15.9M | -$22.8M | -$16.2M | -$9.6M | -$9.9M | |||||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $445.0K | -$262.0K | $246.0K | $801.0K | -$60.0K | $0.00 | $0.00 | $0.00 | ||||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $445.0K | -$247.0K | $232.0K | $849.0K | -$66.0K | $0.00 | $0.00 | $0.00 | ||||||||||
| Comprehensive Income Net Of Tax | -$61.9M | -$55.5M | -$33.8M | -$25.8M | -$26.4M | -$26.9M | -$14.1M | -$15.9M | ||||||||||
| Interest Expense | $41.0K | $48.0K | $66.0K | $104.0K | $121.0K | $1.8M | $2.0M | $107.0K | $153.0K | |||||||||
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Selling General And Administrative Expense | $17.4M | $15.1M | $12.2M | $8.2M | $7.4M | $7.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $739.8M | $443.6M | $345.1M | $176.6M | -$64.2M | -$28.8M | -$10.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $91.4M | $192.7M | $360.6M | $194.8M | $88.2M | $25.9M | $3.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$101.3M | -$167.9M | $165.8M | $106.6M | $62.3M | $1.5M | |
| Cash And Cash Equivalents At Carrying Value | $91.1M | $192.4M | $360.4M | $194.6M | $88.0M | $4.5M | |
| Retained Earnings Accumulated Deficit | -$510.2M | -$298.0M | -$188.6M | -$112.2M | -$65.4M | -$112.8M | |
| Liabilities Current | $36.6M | $23.3M | $21.4M | $22.6M | $13.4M | $24.9M | |
| Liabilities And Stockholders Equity | $806.9M | $496.8M | $368.0M | $200.2M | $92.4M | $8.3M | |
| Assets | $806.9M | $496.8M | $368.0M | $200.2M | $92.4M | $8.3M | |
| Liabilities | $67.1M | $53.2M | $22.9M | $23.6M | $14.8M | $30.2M | |
| Assets Current | $803.9M | $493.6M | $365.7M | $198.5M | $90.5M | $5.1M | |
| Accounts Payable Current | $9.0M | $7.9M | $12.6M | $16.2M | $2.6M | $2.4M | |
| Common Stock Value | $4.0K | $3.0K | $2.0K | $2.0K | $0.00 | $2.0K | |
| Accrued Liabilities Current | $15.6M | $8.1M | $6.2M | $6.1M | $4.1M | $492.6K | |
| Other Assets Noncurrent | $726.0K | $838.0K | $234.0K | $116.0K | $180.0K | ||
| Property Plant And Equipment Net | $1.2M | $751.0K | $170.0K | $168.0K | $106.0K | $294.0K | |
| Operating Lease Right Of Use Asset | $1.1M | $1.6M | $1.9M | $1.4M | $1.6M | ||
| Noncash Lease Expense | $473.0K | $433.0K | $290.0K | $211.0K | $160.0K | ||
| Operating Lease Liability Noncurrent | $1.3M | $1.5M | $1.4M | $1.0M | $1.3M | ||
| Operating Lease Liability Current | $611.0K | $130.0K | $665.0K | $307.0K | $319.0K | ||
| Stock Issued During Period Value Sale Of Common Stock In At The Market Offerings | $9.8M | $14.8M | $26.4M | ||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $141.9M | $0.00 | ||
| Common Stock In At The Market Offerings Net Of Issuance Costs | $518.0K | $742.0K | |||||
| Change In Fair Value Of Contingent Value Right Liability |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $573.4M | $614.2M | $660.4M | $468.0M | $488.8M | $338.1M | $359.0M | $371.2M | $232.9M | -$98.5M | -$82.8M | -$73.7M | $140.9M | $157.7M | $171.2M | -$8.3M | -$6.6M | $10.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $140.9M | $127.6M | $122.9M | $192.9M | $280.9M | $342.9M | $370.7M | $377.7M | $236.6M | $55.7M | $65.3M | $74.5M | $150.4M | $167.8M | $185.3M | $13.5M | $6.5M | $13.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$69.8M | -$17.8M | $41.8M | $13.7M | $180.5M | $1.4M | $10.2M | ||||||||||||
| Cash And Cash Equivalents At Carrying Value | $140.7M | $127.3M | $122.7M | $192.6M | $280.7M | $342.6M | $370.5M | $377.6M | $236.4M | $101.7M | $108.7M | $119.1M | $150.1M | $167.5M | $185.0M | $1.4M | $0.00 | ||
| Retained Earnings Accumulated Deficit | -$449.7M | -$387.3M | -$332.1M | -$268.5M | -$241.9M | -$215.6M | -$165.1M | -$150.9M | -$135.0M | -$210.3M | -$207.0M | -$199.9M | -$166.9M | -$148.3M | -$131.9M | -$500.9K | |||
| Liabilities Current | $26.7M | $20.6M | $18.7M | $25.5M | $20.3M | $14.9M | $14.4M | $9.7M | $10.0M | $1.5M | $6.4M | $12.7M | $12.7M | $11.5M | $13.8M | $552.4K | |||
| Liabilities And Stockholders Equity | $630.5M | $665.1M | $709.3M | $495.1M | $510.2M | $354.2M | $376.5M | $384.2M | $243.8M | $106.0M | $113.3M | $124.3M | $155.5M | $172.4M | $189.4M | $122.4M | |||
| Assets | $630.5M | $665.1M | $709.3M | $495.1M | $510.2M | $354.2M | $376.5M | $384.2M | $243.8M | $106.0M | $113.3M | $124.3M | $155.5M | $172.4M | $189.4M | $122.4M | |||
| Liabilities | $57.1M | $50.9M | $48.9M | $27.2M | $21.4M | $16.1M | $17.5M | $13.0M | $10.9M | $1.5M | $6.4M | $12.7M | $14.7M | $14.7M | $18.2M | $4.8M | |||
| Assets Current | $627.2M | $661.6M | $705.6M | $493.2M | $508.2M | $351.9M | $374.3M | $381.7M | $242.1M | $104.7M | $113.1M | $124.1M | $154.8M | $171.3M | $188.6M | $1.6M | |||
| Accounts Payable Current | $7.3M | $6.4M | $6.7M | $3.6M | $4.7M | $5.3M | $8.5M | $5.2M | $5.6M | $1.1M | $1.6M | $5.1M | $939.0K | $1.5M | $3.6M | $40.5K | |||
| Common Stock Value | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | ||||
| Accrued Liabilities Current | $11.1M | $6.2M | $4.1M | $5.5M | $4.5M | $8.8M | $5.6M | $4.1M | $4.0M | $462.0K | |||||||||
| Other Assets Noncurrent | $840.0K | $840.0K | $839.0K | $236.0K | $236.0K | $235.0K | $116.0K | $116.0K | $116.0K | $1.4M | $204.0K | $217.0K | $232.0K | $559.0K | $225.0K | ||||
| Property Plant And Equipment Net | $1.2M | $1.3M | $1.4M | $79.0K | $98.0K | $211.0K | $183.0K | $159.0K | $180.0K | $180.0K | $229.0K | $229.0K | |||||||
| Operating Lease Right Of Use Asset | $1.2M | $1.3M | $1.5M | $1.7M | $1.6M | $1.8M | $1.9M | $1.3M | $200.0K | ||||||||||
| Noncash Lease Expense | $112.0K | $142.0K | $84.0K | $74.0K | |||||||||||||||
| Operating Lease Liability Noncurrent | $1.4M | $1.6M | $1.6M | $1.7M | $1.1M | $1.3M | $1.6M | $1.8M | $945.0K | ||||||||||
| Operating Lease Liability Current | $656.0K | $632.0K | $479.0K | $76.0K | $759.0K | $767.0K | $353.0K | $321.0K | $313.0K | ||||||||||
| Stock Issued During Period Value Sale Of Common Stock In At The Market Offerings | $9.8M | $14.8M | $4.9M | $14.6M | |||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Common Stock In At The Market Offerings Net Of Issuance Costs | $518.0K | $119.0K | $408.0K | ||||||||||||||||
| Change In Fair Value Of Contingent Value Right Liability | $0.00 | $0.00 | $0.00 | -$1.5M | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | $473.4M | $218.3M | $239.4M | $149.0M | $89.9M | $34.2M |
| Net Cash Provided By Used In Operating Activities | -$180.4M | -$93.9M | -$73.5M | -$42.3M | -$27.5M | -$32.7M |
| Increase Decrease In Accounts Payable | $1.1M | -$4.7M | -$3.7M | $526.0K | $1.3M | -$2.4M |
| Net Cash Provided By Used In Investing Activities | -$394.3M | -$292.3M | -$89.0K | -$151.0K | -$68.0K | -$22.0K |
| Share Based Compensation | $34.3M | $16.8M | $5.5M | $2.1M | $507.0K | $983.0K |
| Proceeds From Stock Options Exercised | $8.6M | $3.0M | $2.7M | $219.0K | $68.0K | $163.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $8.9M | -$1.6M | $1.2M | -$352.0K | $1.4M | -$1.7M |
| Payments To Acquire Property Plant And Equipment | $933.0K | $505.0K | $89.0K | $151.0K | $68.0K | $22.0K |
| Increase Decrease In Operating Lease Liability | $186.0K | -$495.0K | -$54.0K | -$319.0K | -$141.0K | |
| Increase Decrease In Accrued Liabilities | $2.0M | $1.5M | $1.5M | |||
| Depreciation Depletion And Amortization | $281.0K | $156.0K | $100.0K | $89.0K | $32.0K | |
| Proceeds From Issuance Of Common Stock | $0.00 | $53.5M | $0.00 | $20.1M | ||
| Proceeds From Stock Plans | $578.0K | $441.0K | $0.00 | |||
| Increase Decrease In Other Operating Assets | $0.00 | -$64.0K | $64.0K | -$2.0K | ||
| Payments To Acquire Marketable Securities | $849.6M | $386.6M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q3 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | $244.3M | $15.9M | $77.3M | $55.0K | $195.5M | $122.4M | $20.1M |
| Net Cash Provided By Used In Operating Activities | -$41.4M | -$33.6M | -$35.5M | -$13.7M | -$15.0M | -$190.6K | -$9.9M |
| Increase Decrease In Accounts Payable | -$1.3M | -$7.4M | -$10.8M | -$982.0K | $2.2M | $39.5K | $715.0K |
| Net Cash Provided By Used In Investing Activities | -$272.6M | -$67.0K | -$29.0K | -$100.0K | -$120.8M | ||
| Share Based Compensation | $6.4M | $4.1M | $1.0M | $332.0K | $1.6M | $94.0K | |
| Proceeds From Stock Options Exercised | $575.0K | $806.0K | $222.0K | $55.0K | $4.0K | $10.0K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $7.2M | $4.1M | $908.0K | -$3.2M | $3.1M | -$117.0K | |
| Payments To Acquire Property Plant And Equipment | $851.0K | $67.0K | $29.0K | $100.0K | |||
| Increase Decrease In Operating Lease Liability | $435.0K | -$75.0K | -$76.0K | -$77.0K | |||
| Increase Decrease In Accrued Liabilities | $671.0K | -$2.1M | -$18.0K | $392.0K | |||
| Depreciation Depletion And Amortization | $20.0K | $26.0K | $25.0K | $18.0K | |||
| Proceeds From Issuance Of Common Stock | $34.2M | $0.00 | $25.0K | $20.1M | |||
| Proceeds From Stock Plans | $287.0K | $245.0K | $0.00 | ||||
| Increase Decrease In Other Operating Assets | $0.00 | $64.0K | $225.0K | ||||
| Payments To Acquire Marketable Securities | $347.3M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$6.01 | -$3.96 | -$3.42 | -$45.05 | -$40.95 | -$2.70 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 84.2M | 10.0M |
| Weighted Average Number Of Shares Outstanding Basic | 35.3M | 27.6M | 22.3M | 1.0M | 878.4K | |
| Weighted Average Number Of Diluted Shares Outstanding | 35.3M | 27.6M | 22.3M | 1.0M | 878.4K | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Earnings Per Share Basic | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-40.95 | |
| Common Stock Shares Outstanding | 37.9M | 29.9M | 24.4M | 17.4M | 909.4K | 15.6M |
| Common Stock Shares Issued | 37.9M | 29.9M | 24.4M | 17.4M | 919.6K | 15.6M |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 108.1M | 250.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 84.2M | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 84.2M | 0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 40.4M | 15.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.77 | -$1.58 | -$1.02 | -$0.89 | -$1.03 | -$1.09 | -$0.58 | -$0.74 | -$1.20 | -$16.82 | -$10.14 | -$10.67 | -$0.43 | -$0.38 | -$0.59 | -$0.65 | -$0.44 | -$0.67 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | |||||||||
| Weighted Average Number Of Shares Outstanding Basic | 35.2M | 35.0M | 33.3M | 29.9M | 25.6M | 24.8M | 24.3M | 21.5M | 19.0M | 960.3K | 944.7K | 923.8K | 43.1M | 43.0M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 35.2M | 35.0M | 33.3M | 29.9M | 25.6M | 24.8M | 24.3M | 21.5M | 19.0M | 960.3K | 944.7K | 923.8K | 43.1M | 43.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Earnings Per Share Basic | $-1.77 | $-1.58 | $-1.02 | $-0.89 | $-1.03 | $-1.09 | $-0.58 | $-0.74 | $-1.20 | $-16.82 | $-10.14 | $-10.67 | $-0.43 | $-0.38 | |||||
| Common Stock Shares Outstanding | 35.0M | 34.7M | 34.6M | 29.7M | 29.7M | 24.7M | 24.1M | 22.9M | 19.6M | 43.3M | 43.2M | 43.2M | 43.1M | 43.1M | 43.0M | ||||
| Common Stock Shares Issued | 35.0M | 34.7M | 34.6M | 29.7M | 29.7M | 24.7M | 24.1M | 22.9M | 19.6M | 43.3M | 43.2M | 43.2M | 43.1M | 43.1M | 43.0M | ||||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 43.2M | 43.1M | 43.0M | 32.0M | 15.3M | 15.3M | 14.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $8.6M | $3.0M | $2.8M | $219.0K | $68.0K | $164.0K |
| Stock Granted During Period Value Sharebased Compensation | $34.3M | $16.8M | $5.5M | $2.1M | $507.0K | $983.0K |
| Interest Income Other | $27.8M | $21.3M | $14.8M | $709.0K | $14.0K | $37.0K |
| Additional Paid In Capital | $1.25B | $741.3M | $533.8M | $288.8M | $1.2M | $91.0M |
| Prepaid Expense Current | $3.9M | $2.4M | $562.0K | |||
| Interest Paid Net | $2.8M | $198.0K | $0.00 | $307.0K | $345.0K | |
| Capital Expenditures Incurred But Not Yet Paid | $245.0K | $13.0K | $0.00 | $10.0K | ||
| Investment Income Interest | ||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $578.0K | $441.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $1.5M | $892.0K | $575.0K | $401.0K | $567.0K | $806.0K | $607.0K | $242.0K | $1.1M | $22.0K | $86.0K | $55.0K | $71.0K | $106.0K | $4.0K | $3.0K | $9.0K | $10.0K | |
| Stock Granted During Period Value Sharebased Compensation | $9.5M | $8.4M | $6.4M | $4.3M | $4.1M | $4.1M | $1.3M | $1.3M | $1.0M | $382.0K | $382.0K | $332.0K | $1.7M | $2.9M | $1.6M | $161.0K | $138.0K | $94.0K | |
| Interest Income Other | $6.4M | $7.1M | $6.9M | $6.4M | $4.6M | $4.5M | $4.8M | $2.9M | $2.4M | $269.0K | $45.0K | $7.0K | $5.0K | $5.0K | $1.0K | $1.5K | |||
| Additional Paid In Capital | $1.02B | $1.00B | $991.9M | $735.8M | $730.8M | $553.7M | $524.0M | $522.2M | $367.9M | $314.9M | $313.9M | $311.5M | $307.7M | $306.0M | $303.0M | $5.5M | |||
| Prepaid Expense Current | $7.3M | $9.3M | $5.3M | $3.7M | $4.1M | $5.7M | $2.9M | $4.5M | $4.7M | $4.7M | $3.8M | $3.6M | $169.6K | ||||||
| Interest Paid Net | $698.0K | $0.00 | $47.0K | $60.0K | $59.0K | ||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $8.0K | $11.0K | ||||||||||||||||
| Investment Income Interest | $5.0K | $5.0K | $1.0K | $1.0K | $36.0K | ||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $291.0K | $287.0K | $196.0K | $245.0K | $11.0K |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.